SCHEMBL1020703

SCHEMBL1020703

CCN(CC)CCOc1ccc2c(c1)CCN(S(=O)(=O)c1ccc(Oc3ccc(F)cc3)cc1)C2OC(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 7/20 0.43
MMP2 P08253 6/20 0.43
MMP9 P14780 6/20 0.43
MMP12 P39900 5/20 0.43
MMP14 P50281 5/20 0.43
MMP15 P51511 5/20 0.43
MMP16 P51512 5/20 0.43
MMP26 Q9NRE1 5/20 0.43
MMP7 P09237 4/20 0.43
TAS2R14 Q9NYV8 1/20 0.40
ADAM17 P78536 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
CACNA1H O95180 1/20 0.39
CACNA1B Q00975 1/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
CA14 Q9ULX7 2/20 0.39
CA7 P43166 1/20 0.39
HCRTR1 O43613 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1020994 0.94 MMP1 (0.50) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1021054 0.92 MMP1 (0.43) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1021470 0.91 MMP1 (0.45) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1024879 0.89 MMP1 (0.46) MMP1MMP2MMP9MMP12MMP14
SCHEMBL3532212 0.87 MMP1 (0.48) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1022000 0.86 MEN1 (0.46) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1023199 0.86 MMP1 (0.51) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1021326 0.86 ESR1 (0.51) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1024080 0.86 MMP1 (0.53) MMP1MMP2MMP9MMP12MMP14
SCHEMBL1021053 0.85 MMP1 (0.47) MMP1MMP2MMP9MMP12MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869001-B1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI AVENTIS (FR) 2011-01-12 EP disclosed
EP-1869001-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE Sanofi-Aventis (FR) 2007-12-26 EP disclosed
WO-2006102998-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI-AVENTIS (DE) 2006-10-05 WO disclosed